Ireland· IE-PA-PPA0465/499/001
innohep 4,500 IU, solution for injection
A tinzaparin product containing tinzaparin sodium, registered in Ireland by PCO Manufacturing Ltd.. The same ATC class is registered in 9 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tinzaparin is registered in 9 of 19 countries.
Countries holding a registration under ATC B01AB10 (tinzaparin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 3 of them publish a price we can compare per daily dose
Tinzaparin · ATC B01AB10
9 / 19 countries
- Belgiumprice
- Canada
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Netherlands
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Tinzaparin sodium
- Manufacturer
- PCO Manufacturing Ltd.
- Country
- Ireland (IE)
- ATC code
- B01AB10
- ATC class
- Tinzaparin
- Defined daily dose
- 3.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPPA0465/499/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
162 interactions on record for tinzaparin.
Graded by severity as the source publishes them — 94 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Tinzaparin · interactions on record
162 records
- 94 severe
- 68 moderate
Most severe, free to view
- WarfarinB01AA03severe
- HeparinB01AB01severe
- Antithrombin IIIB01AB02severe
- DalteparinB01AB04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Tinzaparin in 4 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandInnohepLeo Pharma A/S
- CanadaINNOHEPLEO PHARMA INC
- BelgiumInnohep 10000 anti-Xa U/0,5 mlLeo Pharma
- GermanyInnohepLeo Pharma A/S
Authorised across Europe · EMA
The same active substance is authorised in 15 EEA countries. Names it is sold under:
- Belgium · Innohep
- Cyprus · Innohep
- Germany · Innohep, Innohep Multi
- Denmark · Innohep
- Spain · Innohep
- Finland · Innohep, Innohep®
- France · Innohep
- United Kingdom (Northern Ireland) · Innohep, Tinzaparin
- Greece · Innohep
- Italy · Innohep
- Luxembourg · Innohep
- Netherlands · Innohep
- Portugal · Innohep
- Romania · Innohep
- Sweden · Innohep
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d9d9e479-bdb1-4577-abb5-b0f9290baabf GET /v1/drugs/d9d9e479-bdb1-4577-abb5-b0f9290baabf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"B01AB",
"B01AB10"
],
"strength": null,
"pa_number": "PPA0465/499/001",
"substances": [
"Tinzaparin sodium"
],
"legal_basis": "Parallel importation notified in accordance with Article 76(3) of Directive 2001/83/EC",
"market_info": "Unknown",
"authorised_at": "03/03/2023",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tinzaparin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.